BDF Gestion Trims Stock Holdings in Teleflex Incorporated (NYSE:TFX)

BDF Gestion cut its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 11.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,556 shares of the medical technology company’s stock after selling 854 shares during the period. BDF Gestion’s holdings in Teleflex were worth $1,167,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Cromwell Holdings LLC increased its holdings in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 49 shares during the period. Avior Wealth Management LLC grew its position in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares during the last quarter. Ashton Thomas Securities LLC acquired a new position in Teleflex in the 3rd quarter valued at $40,000. True Wealth Design LLC raised its position in Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after buying an additional 166 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Teleflex by 131.1% in the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after acquiring an additional 97 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Trading Up 1.2 %

NYSE:TFX opened at $182.71 on Friday. Teleflex Incorporated has a 52-week low of $171.69 and a 52-week high of $256.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The stock has a fifty day simple moving average of $182.26 and a 200-day simple moving average of $213.50. The company has a market capitalization of $8.49 billion, a PE ratio of 36.32, a price-to-earnings-growth ratio of 1.78 and a beta of 1.16.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.64 earnings per share. On average, equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on TFX. Mizuho cut their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Truist Financial decreased their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.